United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

wallace manufacturing chemists ltd - vitamin a; ergocalciferol; ascorbic acid; thiamine nitrate; riboflavin; pyridoxine hydrochloride; nicotinamide; calcium pantothenate; alpha tocopheryl acetate - oral capsule - 5000unit ; 500unit ; 40mg ; 2.5mg ; 2.5mg ; 1mg ; 20mg ; 5mg ; 2unit

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium anhydrous (unii: 957e53wv42) (riboflavin 5'-phosphate - unii:7n464ure7e), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), sodium pantothenate (unii: oes0r93f0c) (pantothenic ac - known hypersensitivity to any of the components, e.g. thiamine or methyl parahydroxybenzoate. soluvit n must not be given undiluted. when soluvit n is diluted with water based solutions, the admixture should be protected from light. this is not necessary if soluvit n is diluted with intralipid because of the protective effect of the fat emulsion. interference with clinical laboratory tests biotin may interfere with laboratory tests that are based on a biotin/streptavidin interaction, leading to either falsely decreased or falsely increased test results, depending on the assay. the risk of interference is higher in children and patients with renal impairment and increases with higher doses. when interpreting results of laboratory tests, possible biotin interference has to be taken into consideration, especially if a lack of coherence with the clinical presentation is observed (e.g. thyroid test results mimicking graves' disease in asymptomatic patients taking biotin or false negative troponin test results in p

United States - English - NLM (National Library of Medicine)

exeltis usa, inc. - beta carotene (unii: 01yae03m7j) (beta carotene - unii:01yae03m7j), vitamin a acetate (unii: 3le3d9d6oy) (vitamin a - unii:81g40h8b0t), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), levomefolate calcium (unii: a9r10k3f2f) (levomefolic acid - unii:8s95dh25xc), cobalamin (unii: 8406ey2oqa) (cobalamin - unii:8406ey2oqa), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), magnesium oxide (unii: 3a3u0gi71g) (magnesium cation - unii:t6v3lhy838), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - .beta.-carotene 600 [iu] - select-ob+dha ® is indicated to provide vitamin, mineral, and omega-3 fatty acid supplementation prior to conception, throughout pregnancy, and during the postnatal period for the lactating and non-lactating mother.* select-ob+dha ® does not contain fish, fish oils, fish proteins or fish byproducts. select-ob+dha ® is contraindicated in patients with hypersensitivity to any of its components or color additives. folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid. iron therapy is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.), pyridoxine responsive anemia, or cirrhosis of the liver. cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (vitaminb12).

United States - English - NLM (National Library of Medicine)

westminster pharmaceuticals, llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), biotin (unii: 6so6u10h04) (b - wescaps is an orally administered prescription vitamin b dietary supplement formulated for the dietary management of persons who require increases amounts of folic acid and pyridoxine; it also includes vitamin c. wescaps should be administered under the supervision of a licensed medical practitioner.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - pyridoxine hydrochloride - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - pyridoxine hydrochloride - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

br pharmaceuticals ltd - pyridoxine hydrochloride - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

phoenix healthcare distribution ltd - pyridoxine hydrochloride - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - pyridoxine hydrochloride - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

inventica pharma ltd - pyridoxine hydrochloride - oral tablet - 10mg